↳
Global Clinical Trial Momentum: Eye Disease, Lung Cancer, and OX40 Immunotherapy Lead the Next Wave of Innovation
Introduction The clinical trial ecosystem continues to witness remarkable progress, with biopharmaceutical leaders advancing treatments that could redefine patient outcomes in ophthalmology, oncology, and immunotherapy. Recent coverage…
Read story →